Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
1,444.80Prev. Close
1,453.50Volume
0Total traded value
NAUpper Circuit
1,744.20Lower Circuit
1,162.80Fundamentals
| Market Cap | ₹15,193Cr |
| ROE | 20.50% |
| P/E Ratio(TTM) | 42.66 |
| EPS(TTM) | 34.04 |
| P/B Ratio | 8.38 |
| Dividend Yield | 0.60% |
| Industry P/E | 33.73 |
| Book Value | 173.27 |
| Debt to Equity | 0.00 |
| Face Value | 1 |
Understand Fundamentals
Financials
About Concord Biotech
Concord Biotech is a global company that uses the natural process of fermentation to create essential pharmaceutical ingredients for medicines, especially immunosuppressants and oncology drugs. Its main vision is to create biotechnology-based products and services that enrich people's lives by continuously growing its scientific expertise and capabilities. The company holds a strong market position with over 20% market share by volume in five of its key molecules.;
| Parent Organisation | Concord Biotech |
| Managing Director | Mr. Ankur Vaid |
| NSE Symbol | CONCORDBIO |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 41.75 | ||
| Cohance Lifesciences | NA (0.00%) | 80.38 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.68 | ||
| Wockhardt | NA (0.00%) | -423.96 |